OpGen Inc (OPGN) is more of a gamble than an investment
OpGen Inc (OPGN) currently trades at $2.28 and has fallen by 4.60% today. OPGN went down $0.11 from the previous closing price of $2.39. The high forecast for OpGen Inc is $5.00 and the low is $2.00. The company’s market cap is $27.20 million with a 52 week high of $15.20 and a 52 week low of $0.92. OPGN has changed in price by -9.12 per share in the last 12 months.
OpGen Inc has a weak EPS of -7.7. This means the company lost $-7.7 per share after paying dividends, this can indicate that the stock is a risky investment. EPS is calculated as a company’s profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company’s profitability. It is common for a company to report EPS that is adjusted for extraordinary items and potential share dilution. Based on this information, investorsQ rates this stock 4 out of 10. We give it this rating based on current information written in this article.
About OpGen Inc:
OpGen, Inc. operates as a microbial genetics analysis company. The Company offers a platform for automated and microbial whole genome analysis that brings comparative genomics, whole genome sequence assembly, and strain characterization into the laboratory. OpGen serves customers throughout the United States.